Industry Focus

MannKind and Orexigen: two companies with big promise, but can they deliver on profit? Healthcare analyst Michael Douglass and healthcare contributor Todd Campbell discuss the risks facing these biotech stocks.

Direct download: 150311_IF_Healthcare.mp3
Category:Podcast -- posted at: 4:48pm EDT

Are shares of Chipotle copy-cats becoming overvalued? Tune in to find out.

Direct download: 150310_IF_ConsumerGoods.mp3
Category:Podcast -- posted at: 10:12am EDT

1